IriSys Pharmaceutical

IriSys is a contract development and manufacturing organization (CDMO) that provides comprehensive drug development services to the pharmaceutical and biotechnology industries. Founded in 1996 and headquartered in San Diego, the company specializes in formulation development, analytical method development, and cGMP manufacturing for clinical trials and commercial use. Their expertise spans various dosage forms, including oral solids, liquids, topicals, and ophthalmic preparations. In 2021, IriSys was acquired by Recro Pharma to enhance its capabilities in small molecule development and manufacturing. The company is recognized for its ability to handle complex formulations and provide end-to-end support from early-stage development through commercialization.